In the past 52-week period, shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) have moved within the range of $0.50 to $4.24. On the stock’s most recent trading day, the company’s shares ended the regular session at $2.85, which is 32.78% higher than its 52-week high.
AVEO Pharmaceuticals, Inc. (AVEO) has demonstrated a 20-day simple moving average (SMA) of -8.92%, and a 50-day SMA of -17.06%. This public company’s current market capitalization stands at $321.39 million.Analyzing Consensus Estimates, Sales Revenue and Net Income
Measuring Wall Street analysts’ average enthusiasm for a specific stock is critical when considering a potential investment. According to the latest data, the consensus recommendation for AVEO Pharmaceuticals, Inc. (AVEO) is Outperform.
Publicly-traded companies normally report earnings and revenue figures that are either above or below the average Wall Street projection. In the most recent quarterly financial report, for the quarter ending Jun. 2017, AVEO Pharmaceuticals, Inc. (AVEO) delivered a 64.90% surprise with its net revenue.Ownership at AVEO Pharmaceuticals, Inc. (AVEO), According to Most Recent SEC Filings
We can gain important insight by taking a look at institutional ownership, as detailed in public companies’ latest 13F filings. AVEO Pharmaceuticals, Inc. (AVEO) has 0 billion shares outstanding currently, 53.94% of which belong to institutional investors. Those institutional holdings amount to $0.19 billion.
Additionally, according to the most recent 13F filing from AVEO Pharmaceuticals, Inc. (AVEO), there were 21 new positions totaling 12,954,650 shares of the company’s stock. There were 13 sold out positions, on the other hand, totaling 6,294,356 shares.Short, Medium and Long Term Indicators
Analyzing the average trade volume of a publicly-traded company’s stock – in the short, medium and long terms – is helpful for gaining insight into trading activity and general investor sentiment. AVEO Pharmaceuticals, Inc. (AVEO) has had a 20-day average volume of 2,722,600 shares, with an average of 80% of short term indicators pointed at Sell.
The stock’s 50-day average volume has been 3,708,238 shares, with an average of 25% of medium term indicators pointing toward Sell. Finally, its 100-day average volume is 6,401,927 shares with 33% of long-term indicators pointing to Sell.